Your Complete News View.

Published 2 months ago • loading... • Updated 2 months ago

OncoHost partners with Gustave Roussy Cancer Institute

Summary by European Pharmaceutical Manufacturer

OncoHost has announced a collaboration with Gustave Roussy, the first European cancer centre, to identify non-invasive biomarkers for immune-related adverse events (irAEs) in patients undergoing immunotherapy.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

European Pharmaceutical Manufacturer

OncoHost partners with Gustave Roussy Cancer Institute

OncoHost has announced a collaboration with Gustave Roussy, the first European cancer centre, to identify non-invasive biomarkers for immune-related adverse events (irAEs) in patients undergoing immunotherapy.

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 months agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

European Pharmaceutical Manufacturer broke the news in 2 months ago on Monday, March 3, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics